IDT signs contract to supply Research Councils UK with custom oligonucleotides
14-Jul-2010
- USA
“It is fantastic news that we have been selected as a preferred supplier by RCUK. We want researchers in the UK to benefit from IDT’s twenty-year commitment to tireless innovation and peerless quality in oligo synthesis. We can also use this opportunity to learn how IDT can best support research worldwide, as the science and application of synthetic biology advances,” commented Dr. Joseph A. Walder, IDT’s founder and CEO.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.